These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Outcomes of excision of 1750 eyelid and periocular skin basal cell and squamous cell carcinomas by modified en face frozen section margin-controlled technique. Gayre GS; Hybarger CP; Mannor G; Meecham W; Delfanti JB; Mizono GS; Guerry TL; Chien JS; Sooy CD; Anooshian R; Simonds R; Pietila KA; Smith DW; Dayhoff DA; Engman E; Lacy J Int Ophthalmol Clin; 2009; 49(4):97-110. PubMed ID: 20348860 [No Abstract] [Full Text] [Related]
64. Mohs moat: peripheral cutaneous margin clearance in a collaborative approach for aggressive and deeply invasive basal cell carcinoma. Vance KK; Pytynia KB; Antony AK; Krunic AL Australas J Dermatol; 2014 Aug; 55(3):198-200. PubMed ID: 23866002 [TBL] [Abstract][Full Text] [Related]
65. The role of Mohs' micrographic surgery in the management of skin cancer and a perspective on the management of the surgical defect. Lang PG Clin Plast Surg; 2004 Jan; 31(1):5-31. PubMed ID: 15022790 [TBL] [Abstract][Full Text] [Related]
66. The Mohs technique in ophthalmic plastic surgery. Callahan A; Monheit GD; Callahan MA Trans New Orleans Acad Ophthalmol; 1982; 30():364-79. PubMed ID: 7123627 [No Abstract] [Full Text] [Related]
67. The management of eyelid neoplasms. Bedford MA; Migdal CS Trans Ophthalmol Soc U K (1962); 1982 Apr; 102 (Pt 1)():116-8. PubMed ID: 6963042 [TBL] [Abstract][Full Text] [Related]
68. Optimizing the cut in Mohs' micrographic surgery in regard to skin sparing and microscopic view: is a round incision cut necessary? Tilleman TR; Tilleman MM; Neumann MH Clin Exp Dermatol; 2005 Mar; 30(2):116-9. PubMed ID: 15725233 [TBL] [Abstract][Full Text] [Related]
69. The use of Mohs surgery in facial tumors in a patient with Darier's disease. Hamadah I; Grande DJ J Dermatol Surg Oncol; 1991 Dec; 17(12):950-3. PubMed ID: 1960266 [TBL] [Abstract][Full Text] [Related]
70. Cost comparisons of managing complex facial basal cell carcinoma: Canadian study. Lear W; Mittmann N; Barnes E; Breen D; Murray C J Cutan Med Surg; 2008; 12(2):82-7. PubMed ID: 18346405 [TBL] [Abstract][Full Text] [Related]
71. Eyelid basal cell carcinoma arising on the site of a congenital port wine hemangioma. Yan J; Li Y Eye Sci; 2012 Mar; 27(1):44-6. PubMed ID: 22447553 [TBL] [Abstract][Full Text] [Related]
72. The inking brush in Mohs micrographic surgery: a potential source of malignant cell contamination. Kok K; Moncrieff M; Garioch J; Ramaiya A Clin Exp Dermatol; 2014 Jul; 39(5):650-1. PubMed ID: 24766031 [No Abstract] [Full Text] [Related]
74. [Current recommendations in the treatment of basal cell carcinoma and squamous cell carcinoma of the skin]. Kunte C; Konz B Hautarzt; 2007 May; 58(5):419-26. PubMed ID: 17443305 [TBL] [Abstract][Full Text] [Related]
75. Retrospective audit of patients referred for further treatment following Mohs surgery for non-melanoma skin cancer. Wee E; Goh MS; Estall V; Tiong A; Webb A; Mitchell C; Murray W; Tran P; McCormack CJ; Henderson M; Hiscutt EL Australas J Dermatol; 2018 Nov; 59(4):302-308. PubMed ID: 29349770 [TBL] [Abstract][Full Text] [Related]
76. Mohs micrographic surgery: a cost analysis. Cook J; Zitelli JA J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885 [TBL] [Abstract][Full Text] [Related]